Daniel Alfaiate | Medicine | Research Hypothesis Excellence Award

Published on by Research Hypothesis

Research Hypothesis Excellence Award

Daniel Alfaiate
Instituto Politécnico de Castelo Branco, Portugal

Daniel Alfaiate
Affiliation Instituto Politécnico de Castelo Branco
Country Portugal
Scopus ID 58158006300
Documents 3
Citations 31
h-index 2
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0000-0002-5581-4242

Daniel Alfaiate the Research Hypothesis Excellence Award recognizes research activity characterized by a clearly defined scientific problem, systematic investigation, and contributions that can inform further study. Daniel Alfaiate is affiliated with the Instituto Politécnico de Castelo Branco in Portugal and has a publication record centered on sleep medicine, obstructive sleep apnea, sleep physiology, electroencephalography, and the effects of medication on sleep architecture. The documented publications provide a basis for assessing the researcher’s alignment with an international research recognition program in medicine.

Abstract

Daniel Alfaiate’s documented research profile is focused on clinical and physiological aspects of sleep and respiratory medicine. His publications examine topics including psychotropic medication and sleep architecture, obstructive sleep apnea and hematological parameters, wakefulness electroencephalography in patients with obstructive sleep apnea, and body posture among patients receiving non-invasive ventilation. These studies collectively address clinically relevant questions involving sleep physiology, respiratory disorders, diagnostic assessment, and treatment-related factors. The available record reports three documents, 31 citations, and an h-index of 2, providing bibliometric context for evaluating the researcher’s scholarly activity.[1] [2]

Keywords

Daniel Alfaiate; sleep medicine; obstructive sleep apnea; sleep architecture; polysomnography; electroencephalography; non-invasive ventilation; respiratory medicine; psychotropic medication; clinical research; medical research; research hypothesis; Portugal.

Introduction

Sleep medicine integrates clinical observation, physiological measurement, diagnostic technologies, and therapeutic evaluation to investigate disorders affecting sleep and breathing. Obstructive sleep apnea is characterized by recurrent episodes of upper-airway obstruction during sleep and can be studied through clinical assessment and objective sleep-related measurements. Research involving polysomnography, electroencephalography, respiratory parameters, and related physiological indicators can therefore contribute to a more detailed understanding of patient characteristics and treatment considerations.[1] [2] [3] [4]

Research Profile

Daniel Alfaiate is affiliated with the Instituto Politécnico de Castelo Branco in Portugal. The supplied bibliometric profile identifies Scopus Author ID 58158006300 and reports three documents, 31 citations, and an h-index of 2. These values represent the supplied research-profile information and should be interpreted in relation to the indexing date and database coverage.

Research Contributions

The research record contains several contributions to the study of sleep and respiratory disorders. A recent article in the European Journal of Pharmacology investigates the class-specific and cumulative effects of psychotropic medication on sleep architecture using polysomnographic retrospective data. This study addresses the relationship between medication exposure and objectively measured sleep characteristics, providing a clinical pharmacology perspective on sleep physiology. [1]

Publications

The supplied publication record includes the following works. DOI identifiers are provided where available and link directly to the corresponding DOI resolution service.

  1. Alfaiate, D.; Silva, P.; Guerra, P.; Pinto, N.; Pereira, A. “Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study.” European Journal of Pharmacology, 2026-08.
  2. Guerra, P.; Alfaiate, D.; Pinto, N.; Pereira, T.; Pereira, A. “Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study.” Sleep and Breathing, 2025.
  3. Pereira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. “Evaluation of wakefulness electroencephalogram in OSA patients.” Research Square, 2024.

Research Impact

The supplied profile reports 31 citations and an h-index of 2 for Daniel Alfaiate. Bibliometric indicators such as citations and h-index can provide useful measures of scholarly visibility, although they should not be considered comprehensive measures of research quality or clinical significance. Citation counts can vary among databases and change over time.

Award Suitability

Based on the supplied academic record, Daniel Alfaiate’s research activity is relevant to the thematic scope of the International Research Hypothesis Excellence Award. The principal basis for this assessment is the documented concentration on clinically meaningful research questions, publication in recognized scholarly outlets, multidisciplinary collaboration, and use of measurable clinical or physiological variables.

The record demonstrates several characteristics that can be considered in an academic recognition assessment:

  • Hypothesis-driven clinical inquiry: the studies investigate defined relationships involving medication exposure, sleep architecture, obstructive sleep apnea, hematological parameters, electroencephalographic findings, posture, and sleep quality.
  • Evidence-oriented methodology: the publication record includes research using polysomnographic and other objective clinical measurements.

Conclusion

Daniel Alfaiate’s documented research profile presents a coherent body of work in Medicine, particularly in sleep and respiratory research. The publications address medication-related changes in sleep architecture, obstructive sleep apnea and hematological characteristics, wakefulness electroencephalography, and the relationship between body posture and sleep quality during non-invasive ventilation. [1] [2] [4] [5]

References

  1. Alfaiate, D.; Silva, P.; Guerra, P.; Pinto, N.; Pereira, A. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology.
    https://doi.org/10.1016/j.ejphar.2026.179292
  2. Guerra, P.; Alfaiate, D.; Pinto, N.; Pereira, T.; Pereira, A. (2025). Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing.
    https://doi.org/10.1007/s11325-025-03330-2
  3. Pereira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Research Square.
    https://doi.org/10.21203/rs.3.rs-3831506/v1
  4. Ferreira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing.
    https://doi.org/10.1007/s11325-024-03116-y
  5. Alfaiate, D.; Pereira, A.; Guerra, P.; Pinto, N. (2023). Body posture as a factor determining sleep quality in patients using non-invasive ventilation. Sleep and Breathing.
    https://doi.org/10.1007/s11325-023-02817-0

Shiji Fang | Medicine | Best Researcher Award

Published on by Research Hypothesis

Best Researcher Award

Shiji Fang
Lishui Central Hospital, China

Shiji Fang
Affiliation Lishui Central Hospital
Country China
Scopus ID 57192204982
Documents 91
Citations 2,574
h-index 27
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0009-0004-4998-5039

Shiji Fang is a medical researcher affiliated with Lishui Central Hospital in China whose indexed research profile reflects sustained scholarly activity in biomedical and translational medicine. The available Scopus-derived profile records 91 documents, 2,574 citations and an h-index of 27, indicating a substantial body of indexed research and citation activity. [1][2]

Abstract

Shiji Fang’s research profile is situated within medicine and includes a substantial body of indexed scholarly work. The supplied publication record highlights research at the intersection of cancer biology, tumor microenvironment, immunotherapy and nanomedicine. Recent studies address mechanisms and therapeutic approaches involving immunogenic cell death, reactive oxygen species, endoplasmic reticulum stress, cellular senescence, copper homeostasis, ferroptosis, cuproptosis, chemoembolization and MRI-guided therapeutic systems. [1] [2]

Keywords

Shiji Fang; Best Researcher Award; Medicine; cancer research; hepatocellular carcinoma; immunotherapy; nanomedicine; immunogenic cell death; ferroptosis; cuproptosis; tumor biology; therapeutic delivery; translational medicine; oxidative stress; endoplasmic reticulum stress.

Introduction

Contemporary cancer research increasingly integrates molecular oncology with materials science, immunology and targeted therapeutic delivery. Hepatocellular carcinoma in particular presents a complex therapeutic environment in which tumor heterogeneity, immune suppression and resistance mechanisms can limit treatment effectiveness. Research that investigates interactions among tumor cells, immune pathways and therapeutic nanoplatforms therefore forms an important component of translational biomedical investigation.[2] [3]

Research Profile

The supplied Scopus profile identifies Shiji Fang with Author ID 57192204982 and lists Lishui Central Hospital, China, as the institutional affiliation. The profile is associated with the subject area of Medicine and records 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Research characteristics

  • Primary discipline: Medicine.
  • Institutional affiliation: Lishui Central Hospital, China.
  • Scopus Author ID: 57192204982.
  • Indexed documents: 91.
  • Reported citations: 2,574.
  • Reported h-index: 27.
  • Major themes represented: cancer biology, hepatocellular carcinoma, immunotherapy, nanomedicine and regulated cell-death mechanisms.

Research Contributions

The supplied publications indicate several connected areas of research contribution. One strand examines how natural or bioactive compounds can influence cancer-cell death and stress-response pathways. The 2025 article on astragalin investigates immunogenic cell death in liver cancer in connection with NQO2, reactive oxygen species and endoplasmic reticulum stress. [2]

A second strand concerns the integration of cellular senescence with immune activation. The study published in Advanced Science describes a biomimetic nanomedicine approach designed around senescence-modulated immune activation and its potential relationship with immunotherapy efficacy in hepatocellular carcinoma. [3]

Publications

The following selected publications are taken from the supplied Scopus-derived research information. The list emphasizes recent 2025 articles and includes DOI identifiers where provided.

  1. Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
  2. Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
  3. Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
  4. Corrigendum to “Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma”. Cellular Signalling.

Research Impact

The supplied bibliometric indicators provide a quantitative view of the visibility of the research record. With 2,574 reported citations and an h-index of 27 across 91 indexed documents, the profile demonstrates sustained citation activity within the indexed scholarly literature. [1] Bibliometric measures should nevertheless be interpreted alongside publication quality, methodological rigor, authorship contributions and the substantive influence of individual studies.

Award Suitability

The Best Researcher Award within the International Research Hypothesis Excellence Award framework can be assessed using evidence concerning research productivity, scholarly visibility, thematic contribution and relevance to the broader research community. The supplied profile provides several measurable indicators, including 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Conclusion

Shiji Fang’s supplied academic profile presents an established research record in Medicine, with affiliation to Lishui Central Hospital in China and a Scopus Author ID of 57192204982. The reported 91 documents, 2,574 citations and h-index of 27 provide quantitative indicators of scholarly activity and citation visibility. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Shiji Fang, Author ID 57192204982. Scopus.
    https://www.scopus.com/pages/authors/57192204982
  2. Zheng, L., Zhao, Z., Chen, L., Yang, W., Ercolani, G., Qin, P., Lin, B., Han, M., Weng, Q., Zhang, Y., et al. (2025). Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
    https://doi.org/10.1016/j.freeradbiomed.2025.07.047
  3. Fang, S., Zheng, L., Lin, B., Chen, J., Hou, D., Ding, Y., Han, M., Qin, P., Wang, M., Guo, X., et al. (2025). Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
    https://doi.org/10.1002/advs.202517792
  4. Liang, X., Fang, S., Xin, Y., Lei, J., Wang, W., Wei, Y., Li, W., Li, C., Tang, H., Wei, X., et al. (2025). Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
    https://doi.org/10.1186/s12951-025-03722-2
  5. Chen, M., Chen, Y., Chen, W., Chen, X., Guo, X., Yu, J., Guo, X., Wang, M., Zhang, X., Hu, Q., et al. (2025). Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor. Acta Biomaterialia.
    https://doi.org/10.1016/j.actbio.2025.04.042
  6. Chen, X., Zhang, F., Lu, C., Wu, R., Yang, et al. (2025). Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma. ACS Applied Materials and Interfaces.
    https://doi.org/10.1021/acsami.4c21890

Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award | Pharmaceutical | Abdul Wali Khan University Mardan | Pakistan

Dr. Muhammad Bilal Afridi is a dedicated pharmaceutical scientist and clinical pharmacist recognized for his expertise in drug synthesis, pharmacological modeling, and computational chemistry. With a profound academic background and more than a decade of professional experience, Dr. Afridi has established himself as a leading researcher in the domain of synthetic and therapeutic drug development. He earned his Ph.D. in Pharmaceutical Sciences from Abdul Wali Khan University, Mardan, where his doctoral research focused on the synthesis, characterization, computational studies, and pharmacological potential of synthetic curcumin derivatives aimed at addressing diabetes and amnesia-related disorders. His earlier academic milestones include an M.Phil in Pharmaceutical Sciences from Abdul Wali Khan University and a Doctor of Pharmacy (Pharm-D) from Kohat University of Science and Technology. Professionally, Dr. Muhammad Bilal Afridi has served as a pharmacist at the Institute of Kidney Diseases (IKD), Peshawar, where he managed hospital pharmacy operations, clinical pharmacy services, and patient safety programs. His leadership extended to training junior pharmacists, supervising pharmacy interns, and participating in institutional Drug and Therapeutic Committees. His previous tenures at Rehman Medical Institute and D. Watson Chemist allowed him to develop robust skills in patient counseling, prescription review, pharmacovigilance, and rational drug use. Dr. Afridi’s research interests encompass computational drug design, molecular docking, pharmacodynamics, and synthesis of bioactive compounds, reflecting his interdisciplinary approach that bridges chemistry, pharmacology, and computational biology. His published works in highly regarded journals, including Computational Biology and Chemistry, Inorganic Chemistry Communications, and Current Molecular Pharmacology, contribute significantly to advancing medicinal chemistry and pharmaceutical innovation. He has demonstrated strong analytical and technical skills in density functional theory (DFT) modeling, ADMET prediction, and spectral analysis. Dr. Muhammad Bilal Afridi’s professional competencies include teaching, mentoring, research supervision, and scientific writing, backed by proficiency in tools like EndNote and MS Office. His contributions have been acknowledged through multiple peer-reviewed publications, collaborations with international researchers from Türkiye and Saudi Arabia, and recognition in academic circles for his commitment to scientific excellence. He continues to serve as a role model for young researchers in Pakistan through his dedication to patient-centered research and academic mentorship. His unwavering commitment to bridging pharmaceutical sciences and clinical applications makes him a strong candidate for recognition in global research excellence. Dr. Muhammad Bilal Afridi stands as an emerging leader with a promising future in international pharmaceutical research, committed to innovation, integrity, and impactful contributions to human health and medicine.

Profile: Scopus

Featured Publications 

  1. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). SwissADME studies and density functional theory (DFT) approaches of methyl substituted curcumin derivatives. Computational Biology and Chemistry, 112, 108153. (Cited by 8)

  2. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). In silico ADMET and DFT analysis of methoxy substituted curcumin derivatives. Inorganic Chemistry Communications, 168, 112943. (Cited by 6)

  3. Afridi, M. B., Khan, H., Ali Shah, S. W., Zafar, M., Almalki, A. S., Ghias, M., & Rahman, N. (2022). In-vivo anti-nociceptive activities of Schiff bases aldehyde derivatives of 4-aminoantipyrine and their molecular docking studies. Main Group Chemistry, 21(2), 373–386. (Cited by 10)

  4. Afridi, M. B., Khan, H., Akkol, E. K., & Aschner, M. (2021). Pain perception and management: Where do we stand? Current Molecular Pharmacology, 14(5), 678–688. (Cited by 25)

  5. Afridi, M. B., Sardar, H., Shah, S. W. A., Serdaroğlu, G., & Khan, H. (2025). Exploring anticholinergic and anti-amnesic potential of methyl substituted monocarbonyl curcumin derivatives. European Journal of Pharmacology, 950, 182653. (Cited by 2)

  6. Afridi, M. B., Khan, H., & Shah, S. W. A. (2023). Computational evaluation of synthetic curcumin analogs for neuroprotective potential using molecular docking approaches. Journal of Molecular Structure, 1287, 135623. (Cited by 4)

  7. Afridi, M. B., Sardar, H., & Khan, H. (2023). Pharmacological insights into curcumin derivatives: A computational and experimental perspective. Bioorganic Chemistry, 137, 106707. (Cited by 3)

 

Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Medicine and Health Sciences | Head of Department | Wroclaw Medical University | Poland

Assoc. Prof. Dr. Katarzyna Madziarska is a distinguished Polish clinician-scientist, educator, and researcher whose career has been dedicated to advancing the fields of diabetology, nephrology, and internal medicine through outstanding academic leadership, clinical practice, and research excellence. She obtained her MD and PhD from Wroclaw Medical University, where she currently serves as Head of the Clinical Department of Diabetology, Hypertension, and Internal Diseases, a position that allows her to combine patient care with cutting-edge research and medical education. Her professional experience spans decades, including roles as resident, assistant, senior assistant, adjunct, and ultimately associate professor, giving her a comprehensive understanding of clinical and academic medicine. She has been actively involved in postgraduate medical training and serves as a coordinator for trainees, a member of doctoral and habilitation committees, and a lecturer at both undergraduate and postgraduate levels. Her research interests are focused on micro- and macrovascular complications of diabetes, diabetic nephropathy, chronic kidney disease, transplantology, and the long-term health consequences of COVID-19. She has authored 112 documents, 1,076 citations, and 15 h-index, demonstrating her sustained scientific output and influence within the international medical community. Her research skills include designing and coordinating clinical trials (Phase III and IV) as a principal investigator and national coordinator, reviewing manuscripts for international journals, supervising PhD theses, and managing multi-disciplinary research projects like the COLOS study on COVID-19 outcomes. She is also experienced in translational research linking immunological, metabolic, and renal parameters to improve clinical practice. Assoc. Prof. Dr. Katarzyna Madziarska is an active member of prestigious professional bodies such as the Polish Society of Nephrology (President of the Lower Silesia Branch), Polish Society of Diabetology (Board Member), and the Polish Academy of Sciences Clinical Sciences Committee, where she contributes to advancing healthcare policy and scientific development. Her organizational contributions include serving on the Senate and Faculty Council of Medical Sciences at Wroclaw Medical University, membership in the Bioethics Committee, and participation in the Scientific Council for Clinical Trials, demonstrating her commitment to institutional governance and ethical research conduct.

Profile :  Scopus | ORCID

Featured Publications

  1. Diabetes Mellitus and Old Age – Risk Factors in Renal Replacement Therapy – 2020 – Citations: 48

  2. Evaluation of Immunological Parameters in Lipid Metabolism Disturbances in Primary Glomerulonephritis – 2019 – Citations: 35

  3. Microvascular and Macrovascular Complications in Diabetic Nephropathy: Clinical Predictors and Outcomes – 2021 – Citations: 62

  4. Post-COVID-19 Complications and Kidney Function: A Clinical Perspective – 2022 – Citations: 54

  5. Clinical Trials in Diabetes and Chronic Kidney Disease: Lessons from Multicenter Studies – 2023 – Citations: 39

  6. Role of Molecular Mechanisms in Homeostasis Regulation in Nephrology – 2020 – Citations: 42

 

Jian Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Jian Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Jian Liu | Medicine and Health Sciences | Director of Anesthesiology Department | Tongji Hospital in Tongji University | China

Prof. Liu Jianhui is the Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, serving as a Professor, Chief Physician, and PhD Supervisor, as well as an Excellent Academic Leader of the Shanghai Municipal Health Commission and a Shanghai Pujiang Talent. She specializes in perioperative neuroimmunology, leading a research team focused on uncovering the mechanisms and developing intervention strategies for perioperative cognitive dysfunction. She has successfully led multiple high-profile research projects, including several funded by the National Natural Science Foundation of China, and has published influential studies in leading journals such as Journal of Neuroinflammation, Anesthesia & Analgesia, Brain, Behavior and Immunity, and British Journal of Anaesthesia. In addition to her research achievements, she serves on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holds key positions in several national professional committees, reflecting her leadership, academic influence, and dedication to advancing anesthesiology and perioperative medicine.

Professional Profile 

Education  

Prof. Liu Jianhui has pursued an extensive academic path in medicine, specializing in anesthesiology and perioperative medicine, with advanced training that integrates both clinical expertise and research proficiency. She has earned her medical degree followed by postgraduate and doctoral studies, focusing on the intricate mechanisms of perioperative neuroimmunology. Her academic journey has been complemented by specialized training in clinical anesthesia, translational medicine, and neurocognitive function, equipping her with a strong foundation to bridge basic research and clinical application. This comprehensive educational background has enabled her to lead cutting-edge research, mentor doctoral candidates, and contribute significantly to the advancement of anesthesiology at both national and international levels.

Professional Experience

Prof. Liu Jianhui has built a distinguished professional career as Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, where she also serves as Professor, Chief Physician, and PhD Supervisor. She has led numerous research initiatives in perioperative neuroimmunology, with a focus on understanding and addressing perioperative cognitive dysfunction. Her leadership extends beyond the hospital, serving on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holding prominent roles in national professional societies, including the Standing Committee of the Society of Perioperative Basic and Translational Medicine of the Chinese Society of Anesthesiology, the Society of Innovation and Promotion of Cardiothoracic Anesthesia, and the Society of Anesthesia and Brain Function. Through her clinical expertise, academic leadership, and active participation in professional organizations, she has made significant contributions to advancing anesthesiology and perioperative medicine.

Research Interest

Prof. Liu Jianhui’s research interests center on perioperative neuroimmunology, with a particular focus on the mechanisms and intervention strategies for perioperative cognitive dysfunction. She is dedicated to exploring how surgical and anesthetic factors influence neuroimmune pathways and cognitive outcomes, aiming to identify preventive and therapeutic approaches that can improve patient recovery and quality of life. Her work bridges basic science and clinical practice, integrating molecular, cellular, and systemic perspectives to uncover novel targets for intervention. By combining translational research with clinical application, she strives to advance the understanding of brain function in the perioperative period and contribute to the development of evidence-based strategies that enhance patient care in anesthesiology.

Award and Honor

Prof. Liu Jianhui has been recognized with numerous prestigious awards and honors that reflect her exceptional contributions to anesthesiology and medical research. She has been named an Excellent Academic Leader by the Shanghai Municipal Health Commission and honored as a Shanghai Pujiang Talent, acknowledging her leadership, innovation, and impact in her field. Her achievements in advancing perioperative neuroimmunology and cognitive dysfunction research have earned her national recognition, while her influential publications and service on editorial boards highlight her standing in the international academic community. These distinctions underscore her commitment to excellence, her role as a thought leader, and her significant influence on both clinical practice and scientific advancement.

Publications Top Noted

Preoperative tyrosine is associated with postoperative delayed neurocognitive recovery in elderly: Evidence from two hospitals | Year : 2025

Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation | Year : 2025

The Association of Fructose Metabolism With Anesthesia/Surgery-Induced Lactate Production | Year : 2025

Conclusion

Prof. Liu Jianhui’s pioneering research, leadership in anesthesiology, and significant contributions to perioperative neuroimmunology make her a highly deserving candidate for the Best Researcher Award. Her scientific excellence, clinical impact, and commitment to advancing the medical community strongly align with the award’s vision of recognizing transformative contributions to research and healthcare innovation.